| EP1032708 - NUCLEIC ACID LIGANDS OF TISSUE TARGET [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 23.09.2005 Database last updated on 21.03.2026 | Most recent event Tooltip | 17.10.2008 | Change - representative | published on 19.11.2008 [2008/47] | Applicant(s) | For all designated states Schering Aktiengesellschaft Müllerstrasse 170/178 13353 Berlin / DE | [N/P] |
| Former [2001/21] | For all designated states SCHERING AKTIENGESELLSCHAFT Müllerstrasse 170/178 13353 Berlin / DE | ||
| Former [2000/36] | For all designated states NeXstar Pharmaceuticals, Inc. 2860 Wilderness Place, Suite 200, Englewood Boulder, CO 80301 / US | ||
| For all designated states Schering Aktiengesellschaft Müllerstrasse 170-172e 1000 Berlin 65 / DE | Inventor(s) | 01 /
STEPHENS, Andrew 740 Kelly Road West Boulder, CO 80302 / US | 02 /
GOLD, Larry 1033 5th Street Boulder, CO 80302 / US | 03 /
SPECK, Ulrich Fürstendamm 20 D-13465 Berlin / DE | [2000/36] | Representative(s) | Dörries, Hans Ulrich, et al df-mp Patentanwälte Rechtsanwälte PartG mbB Theatinerstraße 16 80333 München / DE | [N/P] |
| Former [2008/47] | Dörries, Hans Ulrich, et al df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | ||
| Former [2001/12] | Dörries, Hans Ulrich, Dr., et al Dörries Frank-Molnia Pohlman Postfach 22 16 61 80506 München / DE | ||
| Former [2000/36] | Dörries, Hans Ulrich, et al Frohwitter Patent- und Rechtsanwälte Possartstrasse 20 81679 München / DE | Application number, filing date | 98960403.8 | 19.11.1998 | [2000/36] | WO1998US25006 | Priority number, date | US19970976413 | 21.11.1997 Original published format: US 976413 | [2000/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9927138 | Date: | 03.06.1999 | Language: | EN | [1999/22] | Type: | A1 Application with search report | No.: | EP1032708 | Date: | 06.09.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.06.1999 takes the place of the publication of the European patent application. | [2000/36] | Search report(s) | International search report - published on: | US | 03.06.1999 | (Supplementary) European search report - dispatched on: | EP | 30.07.2004 | Classification | IPC: | C12P19/34, C12Q1/68, C07H21/00 | [2004/29] | CPC: |
G01N33/76 (EP,US);
A61K47/547 (EP,US);
A61K47/549 (EP,US);
B82Y5/00 (EP,US);
C07H19/06 (EP,US);
C07H19/10 (EP,US);
C07H21/00 (EP,US);
C07K14/001 (EP,US);
C07K14/005 (EP,US);
C07K14/72 (EP,US);
C07K7/22 (EP,US);
C12N15/1048 (EP,US);
C12N15/115 (EP,US);
C12N9/1276 (EP,US);
C12Q1/37 (EP,US);
G01N33/53 (EP,US);
G01N33/531 (EP,US);
G01N33/532 (EP,US);
G01N33/535 (EP,US);
G01N33/56988 (EP,US);
G01N33/68 (EP,US);
A61K38/00 (EP,US);
C12N2310/13 (EP,US);
C12N2310/16 (EP,US);
C12N2310/321 (EP,US);
C12N2310/322 (EP,US);
C12N2310/344 (EP,US);
C12N2310/53 (EP,US);
C12N2740/16222 (EP,US);
C40B40/00 (EP,US);
F02B2075/027 (EP,US);
G01N2333/16 (EP,US);
G01N2333/163 (EP,US);
G01N2333/4724 (EP,US);
G01N2333/503 (EP,US);
G01N2333/575 (EP,US);
G01N2333/62 (EP,US);
G01N2333/7056 (EP,US);
G01N2333/8125 (EP,US);
G01N2333/96433 (EP,US);
G01N2333/96436 (EP,US);
G01N2333/96455 (EP,US);
G01N2333/96486 (EP,US);
G01N2333/966 (EP,US);
G01N2333/9726 (EP,US);
|
| Former IPC [2000/36] | C12Q1/68, C12P19/34, C07H21/02, C07H21/04 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/36] | Extension states | AL | 18.05.2000 | LT | 18.05.2000 | LV | 18.05.2000 | MK | 18.05.2000 | RO | 18.05.2000 | SI | 18.05.2000 | Title | German: | NUKLEINSÄURELIGANDEN FÜR ZIELGEWEBE | [2000/36] | English: | NUCLEIC ACID LIGANDS OF TISSUE TARGET | [2000/36] | French: | LIGANDS D'ACIDE NUCLEIQUE DE CIBLE TISSULAIRE | [2000/36] | Entry into regional phase | 18.05.2000 | National basic fee paid | 18.05.2000 | Search fee paid | 18.05.2000 | Designation fee(s) paid | 18.05.2000 | Examination fee paid | Examination procedure | 18.05.1999 | Request for preliminary examination filed International Preliminary Examining Authority: US | 18.05.2000 | Examination requested [2000/36] | 22.09.2004 | Despatch of a communication from the examining division (Time limit: M06) | 05.04.2005 | Application deemed to be withdrawn, date of legal effect [2005/45] | 10.05.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/45] | Fees paid | Renewal fee | 16.10.2000 | Renewal fee patent year 03 | 22.10.2001 | Renewal fee patent year 04 | 18.10.2002 | Renewal fee patent year 05 | 16.10.2003 | Renewal fee patent year 06 | 19.10.2004 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] JELLINEK D ET AL: "INHIBITION OF RECEPTOR BINDING BY HIGH-AFFINITY RNA LIGANDS TO VASCULAR ENDOTHELIAL GROWTH FACTOR", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 34, no. 33, 30 August 1994 (1994-08-30), pages 10450 - 10456, XP001084739, ISSN: 0006-2960 [A] 1 * the whole document * DOI: http://dx.doi.org/10.1021/bi00200a028 |